Low systolic blood pressure and diastolic dysfunctionare associated with unfavorable outcome in patientswith systolic heart failure: a cohort study
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2026.208997Palabras clave:
Heart failure, Mortality, Hospitalization, Systolic pressure, DiastoleResumen
Background: Despite the significant advances in assessing and treating patients with heart failure, hospitalization and mortality rates are yet high. This study aimed to identify potential clinical and echocardiographic markers associated with adverse outcomes among patients with heart failure presenting mildly or reduced ejection fraction followed for 1-year in a multi-professional heart failure outpatient clinic. Results: This is a prospective cohort study with consecutive patients referred to the heart failure outpatient clinic at the Federal University of São Carlos. We examined all-cause 1-year hospital admission or mortality and time to one of these events. All patients underwent clinical and multi-professional evaluation, echocardiogram, non-pharmacology, and pharmacology prescription. 39 patients were followed for a median of 24 months. Most patients aged 64 ± 14 years, were predominantly in NYHA 2 or 3 (75%) and had a left ventricle ejection fraction of 37 ±12 %. Six patients (15%) were hospitalized during the follow-up period, and 4 patients died. The factors associated with adverse outcomes were low systolic blood pressure (p=0.02) and reduced septal E’ mitral wave(p=0.04). The area under the curve of systolic blood pressure and septal E’ mitral for adverse outcome was, respectively 0.82 [CI: 0.65-0.99; p=0.01] and 0.77 [95% CI: 0.53-1.0; p=0.04]. Conclusions: Low systolic blood pressure and diastolic dysfunction are associated with unfavorable outcomes in a 1-year follow-up of heart failure patients. Systolic blood pressure has high accuracy in predicting the hospitalization or death of patients referred to heart failure outpatient clinics.
Descargas
Referencias
1. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(2):268–310.
2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.
3. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342–56.
4. Marcondes-Braga FG, Moura LAZ, Issa VS, Vieira JL, Rohde LE, Simões MV, et al. Atualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021. Arq Bras Cardiol. 2021;116(6):1174–212.
5. Heo S, Lennie TA, Okoli C, Moser DK. Quality of life in patients with heart failure: Ask the patients. Hear Lung J Cardiopulm Acute Care [Internet]. 2009 Mar 1;38(2):100–8. Available from: https://doi.org/10.1016/j.hrtlng.2008.04.002
6. Gioli-Pereira L, Marcondes-Braga FG, Bernardez-Pereira S, Bacal F, Fernandes F, Mansur AJ, et al. Predictors of one-year outcomes in chronic heart failure: The portrait of a middle income country. BMC Cardiovasc Disord. 2019;19(1):1–7.
7. Chuda A, Banach M, Maciejewski M, Bielecka-Dabrowa A. Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice. Ir J Med Sci. 2021;
8. Chow SL, Maisel AS, Anand I, Bozkurt B, De Boer RA, Felker GM, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the American Heart Association. Vol. 135, Circulation. 2017. 1054–1091 p.
9. Almeida GLG de, Braga F, Jorge JK, Nobre GF, Kalichsztein M, Faria P de MP de, et al. Valor Prognóstico da Troponina T e do Peptídeo Natriurético Tipo B em Pacientes Internados por COVID-19. Arq Bras Cardiol. 2020;115(4):660–6.
10. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J. 2002;23(23):1861–6.
11. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177–232.
12. Lang RM, Badano LP, Victor MA, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr [Internet]. 2015;28(1):1-39.e14. Available from: http://dx.doi.org/10.1016/j.echo.2014.10.003
13. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr [Internet]. 2016;29(4):277–314. Available from: http://dx.doi.org/10.1016/j.echo.2016.01.011
14. Koser KD, Ball LS, Homa JK, Mehta V. An Outpatient Heart Failure Clinic Reduces 30-Day Readmission and Mortality Rates for Discharged Patients: Process and Preliminary Outcomes. J Nurs Res. 2018;26(6):393–8.
15. Kosmala W, Marwick TH, Przewłocka-Kosmala M. Echocardiography in patients with heart failure: Recent advances and future perspectives. Kardiol Pol. 2021;79(1):5–17.
16. Spitaleri G, Lupón J, Domingo M, Santiago-Vacas E, Codina P, Zamora E, et al. Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018. Sci Rep [Internet]. 2021;11(1):1–10. Available from: https://doi.org/10.1038/s41598-020-79926-3
17. Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, et al. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020;106(19):1512–8.
18. Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R. N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease. N Engl J Med. 2005;352(7):666–75.
19. Shrivastava A, Haase T, Zeller T, Schulte C. Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs. Front Cardiovasc Med. 2020;7(November).
20. Liu HH, Cao YX, Jin JL, Guo YL, Zhu CG, Wu NQ, et al. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study. Cardiovasc Diabetol [Internet]. 2021;20(1):1–10. Available from: https://doi.org/10.1186/s12933-021-01271-0
21. van der Meer P, Gaggin HK, Dec GW. ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison. J Am Coll Cardiol. 2019;73(21):2756–68.
22. Yang H, Marwick TH, Wang Y, Nolan M, Negishi K, Khan F, et al. Association between electrocardiographic and echocardiographic markers of stage B heart failure and cardiovascular outcome. ESC Hear Fail. 2017 Nov;4(4):417–31.
23. Carluccio E, Dini FL, Bitto R, Ciccarelli M, Correale M, D’Agostino A, et al. Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study. Int J Cardiol. 2022 Mar;350:62–8.
24. Cautela J, Tartiere JM, Cohen-Solal A, Bellemain-Appaix A, Theron A, Tibi T, et al. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients. Eur J Heart Fail. 2020;22(8):1357–65.
25. Ventura HO, Messerli FH, Lavie CJ. Observations on the blood pressure paradox in heart failure. Eur J Heart Fail. 2017;19(7):843–5.
26. Li Y, Zheng Q, Cui C, Liu Y, Hu Y, Huang D, et al. Application value of myocardial work technology by non-invasive echocardiography in evaluating left ventricular function in patients with chronic heart failure. Quant Imaging Med Surg. 2022;12(1):244–56.
27. Omar AMS, Bansal M, Sengupta PP. Advances in Echocardiographic Imaging in Heart Failure with Reduced and Preserved Ejection Fraction. Circ Res. 2016;119(2):357–74.
28. Lüers C, Edelmann F, Wachter R, Pieske B, Mende M, Angermann C, et al. Prognostic impact of diastolic dysfunction in systolic heart failure—A cross-project analysis from the German Competence Network Heart Failure. Clin Cardiol. 2017;40(9):667–73.
29. Vallebona A, Gigli G, Orlandi S, Orlandi D, Gigli L, Reggiardo G. The Etiology-Filling Pattern-Pulmonary Artery Pressure Score: A Simple Tool for Risk Stratification of Patients with Systolic Heart Failure. Congest Hear Fail. 2013;19(1):39–43.
30. Saraiva RM, De Rocha RCC Da, Martins AF, Duarte DM, Peixoto RDS, De Castro SH, et al. Tissue doppler imaging as a long-term prognostic index in left ventricular systolic dysfunction. Arq Bras Cardiol. 2008;91(2):85–92.
31. Humberto Villacorta ETM. Villacorta & Mesquita Prognostic factors in patients with heart failure. Arq Bras Cardiol. 1999;72(no 3):353–62.
32. Okada K, Mikami T, Kaga S, Onozuka H, Inoue M, Yokoyama S, et al. Early diastolic mitral annular velocity at the interventricular septal annulus correctly reflects left ventricular longitudinalmyocardial relaxation. Eur J Echocardiogr. 2011;12(12):917–23.
33. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol [Internet]. 1997;30(2):474–80. Available from: http://dx.doi.org/10.1016/S0735-1097(97)88335-0
34. Park J-H, Marwick TH. Use and Limitations of E/e’ to Assess Left Ventricular Filling Pressure by Echocardiography. J Cardiovasc Ultrasound. 2011;19(4):169.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Pietro Melo da Silva, Antonione La Martini Silva, Esther Munerato Figueira da Silva, Raquel Martins Loureiro, André Cechinatti, Fabio Rodrigo Prone, Guilherme Casale, Carlos Henrique de Freitas Lima, Henrique Pott-Júnior, Meliza Goi Roscani

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.



